lifestyle.thedishh.com

  • Animals
  • Auto
  • Beauty & Style
  • Business News
  • Entertainment
  • Food
  • Health
  • Home & Family
  • Podcasts
  • Tech
  • Travel

Business

Latest Business News

  • PERFECT GAME DICK’S ALL-AMERICAN CLASSIC HEADED TO CITIZENS BANK PARK IN 2026

    PERFECT GAME DICK’S ALL-AMERICAN CLASSIC HEADED TO CITIZENS BANK PARK IN 2026

    Perfect Game USA
    April 2, 2026
  • White Castle Debuts Brand New Chicken Fajita Slider and Jalapeño Cravioli Side

    White Castle Debuts Brand New Chicken Fajita Slider and Jalapeño Cravioli Side

    Business Wire
    April 2, 2026
  • Veritone and Thorn Partner to Safeguard Children Against Abuse Faster

    Veritone and Thorn Partner to Safeguard Children Against Abuse Faster

    Business Wire
    April 2, 2026
  • Former Obama Campaign Manager Stephanie Cutter Joins Kalshi As Policy Advisor

    Former Obama Campaign Manager Stephanie Cutter Joins Kalshi As Policy Advisor

    Business Wire
    April 2, 2026
  • Biohackers World Completes 2026 Los Angeles Conference with Record Attendance and Expanded Program

    Biohackers World Completes 2026 Los Angeles Conference with Record Attendance and Expanded Program

    EIN Presswire
    April 2, 2026
  • Synthetic Polyisoprene Rubber Market to Reach USD 7.07 Billion by 2035, Led by Asia Pacific and Goodyear,Kraton,ARLANXEO

    Synthetic Polyisoprene Rubber Market to Reach USD 7.07 Billion by 2035, Led by Asia Pacific and Goodyear,Kraton,ARLANXEO

    EIN Presswire
    April 2, 2026
  • YouScan Launches Tiger Finder: AI-Powered TikTok Influencer Discovery

    YouScan Launches Tiger Finder: AI-Powered TikTok Influencer Discovery

    EIN Presswire
    April 2, 2026
  • Former Prosecutor With 50+ Trials Joins Razavi Law Group as Firm Expands Trial Capabilities

    Former Prosecutor With 50+ Trials Joins Razavi Law Group as Firm Expands Trial Capabilities

    Razavi Law Group
    April 2, 2026
  • European Commission Approves KEYTRUDA® (pembrolizumab) Plus Paclitaxel ± Bevacizumab for the Treatment of Adults With PD-L1 (CPS ≥1) Platinum-Resistant Recurrent Ovarian Carcinoma Who Have Received One or Two Prior Systemic Treatment Regimens

    European Commission Approves KEYTRUDA® (pembrolizumab) Plus Paclitaxel ± Bevacizumab for the Treatment of Adults With PD-L1 (CPS ≥1) Platinum-Resistant Recurrent Ovarian Carcinoma Who Have Received One or Two Prior Systemic Treatment Regimens

    Business Wire
    April 2, 2026
  • Oasis Responds to Kao Board’s Opposition: An Open Letter to Fellow Kao Shareholders (4452 JP)

    Oasis Responds to Kao Board’s Opposition: An Open Letter to Fellow Kao Shareholders (4452 JP)

    Business Wire
    April 2, 2026
Prev
1 … 35 36 37 38 39 … 26,229
Next

Channels

Follow Us

  • X
  • LinkedIn

All content ©2025 Tork Media
All Rights Reserved. For more information on this site, please read our Privacy Policy, Terms of Service, Cookie Policy, and Ad Choices.